针对复发或难治性弥漫大B细胞淋巴瘤新药——Tafasitamab

针对复发或难治性弥漫大B细胞淋巴瘤新药——Tafasitamab

Journal of Liaoning University ›› 2022, Vol. 49 ›› Issue (02) : 129-136. DOI: 10.16197/j.cnki.lnunse.2022.02.006

Author information +

History +

CLC number

R979.1

Cite this article

Download Citations

Comments

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉